Neogenomics (NEO) Operating Margin (2010 - 2026)
Neogenomics (NEO) posted Operating Margin of 9.77% for Q1 2026, down 38.53% quarter-over-quarter from 7.05% in Q4 2025, and up 679.0% year-on-year from 1.25% in Q1 2025.
Neogenomics (NEO) Operating Margin (2010 - 2026) Analysis & Trends
Neogenomics (NEO) has reported Operating Margin for 17 consecutive years, with 9.77% the latest figure, recorded in Q1 2026.
- Operating Margin for Q1 2026 came in at 9.77%, up 679.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 14.25% (down 96.0% YoY), and the FY2025 annual result was 15.93%, down 199.0% from the prior year.
- Operating Margin was 9.77% for Q1 2026 at Neogenomics, down from 7.05% in the prior quarter.
- Over five years, Operating Margin peaked at 7.05% in Q4 2025 and troughed at 44.4% in Q1 2022.
- Average Operating Margin over 5 years is 19.4%, with a median of 16.56% recorded in 2025.
- Year-over-year, Operating Margin slumped 3133 bps in 2022 and jumped 1884 bps in 2023.
- Over 5 years, Operating Margin stood at 19.02% in 2022, then jumped by 37 bps to 11.94% in 2023, then advanced by 10 bps to 10.7% in 2024, then soared by 34 bps to 7.05% in 2025, then plunged by 39 bps to 9.77% in 2026.
- Per Business Quant data, the three most recent Operating Margin figures were 9.77% in Q1 2026, 7.05% in Q4 2025, and 14.38% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | -3.71% |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | 16.93% |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | 22.58% |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | 31.78% |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | -13.42% |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | 21.74% |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | 12.38% |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | 19.16% |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | 25.23% |
| 10 | Neogenomics | 1.93 Bn | 1.79 Bn | 80.86 Mn | -9.77% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9.77% |
| Dec 31, 2025 | -7.05% |
| Sep 30, 2025 | -14.38% |
| Jun 30, 2025 | -26.27% |
| Mar 31, 2025 | -16.56% |
| Dec 31, 2024 | -10.70% |
| Sep 30, 2024 | -12.63% |
| Jun 30, 2024 | -13.34% |
| Mar 31, 2024 | -19.56% |
| Dec 31, 2023 | -11.94% |
| Sep 30, 2023 | -15.92% |
| Jun 30, 2023 | -20.35% |
| Mar 31, 2023 | -25.56% |
| Dec 31, 2022 | -19.02% |
| Sep 30, 2022 | -30.68% |
| Jun 30, 2022 | -31.74% |
| Mar 31, 2022 | -44.40% |
| Dec 31, 2021 | -33.06% |
| Sep 30, 2021 | -32.73% |
| Jun 30, 2021 | -18.38% |